Sector consensus Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.550 USD | +16.78% |
|
+16.39% | +29.09% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 12.93 | +325.44% | 15 | ||||||
| 665.48 | +24.48% | 23 | ||||||
| 188.57 | +3.57% | 21 | ||||||
| 225.47 | +17.96% | 19 | ||||||
| 412.35 | +47.32% | 27 | ||||||
| 254,025.79 | +53.12% | 24 | ||||||
| 255.9 | +11.93% | 18 | ||||||
| 443.5 | -15.86% | 12 | ||||||
| 71.03 | +3% | 14 | ||||||
| 105.91 | +30.47% | 23 | ||||||
| 175.31 | +3.21% | 16 | ||||||
| 67.92 | -4.33% | 13 | ||||||
| 215.33 | -0.19% | 15 | ||||||
| 66.53 | +18.51% | 15 | ||||||
| 130.53 | -1.53% | 12 | ||||||
| 48.12 | -12.63% | 16 | ||||||
| 617.67 | +88.43% | 18 | ||||||
| 123.05 | +13.81% | 21 | ||||||
| 43.96 | +11.55% | 14 | ||||||
| 45.76 | +17.8% | 17 | ||||||
| Average | 12,897.06 | +31.80% | 18 | ||||||
| Weighted average by Cap. | 18,659.1 | +19.22% | 19 |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
